Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sesderma LACTYFERRIN and ZINC Defense in Non-hospitalized COVID-19
NCT05783180Phase 2Withdrawn
- Sponsor
- Jose David Suarez
- Start
- Jun 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of Lactyferrin, Sesderma Zinc Defense in coronavirus disease 2019 (COVID-19), sponsored by Jose David Suarez. Planned start Jun 2023; status: withdrawn.
02
Drugs
LactyferrinSesderma Zinc Defense
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05783180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05783180.